tiprankstipranks
Advertisement
Advertisement

HK:1952 Stock Latest News

Everest Medicines Substantial Shareholder CBC Group Raises Stake
Company AnnouncementsEverest Medicines Substantial Shareholder CBC Group Raises Stake
2d ago
1952
Everest Medicines Secures Greater China Rights to Presbyopia Eye Drop LNZ100
PremiumCompany Announcements
Everest Medicines Secures Greater China Rights to Presbyopia Eye Drop LNZ100
4d ago
1952
Everest Medicines Gains Vote of Confidence as Major Shareholder Boosts Stake
PremiumCompany Announcements
Everest Medicines Gains Vote of Confidence as Major Shareholder Boosts Stake
8d ago
1952
Everest Medicines Sets 2026 Virtual AGM, Seeks Fresh Share Repurchase and Issuance Mandates
PremiumCompany Announcements
Everest Medicines Sets 2026 Virtual AGM, Seeks Fresh Share Repurchase and Issuance Mandates
9d ago
1952
Everest Medicines Calls Virtual EGM to Approve Share Purchase Deal
PremiumCompany Announcements
Everest Medicines Calls Virtual EGM to Approve Share Purchase Deal
9d ago
1952
Everest Medicines Out-Licenses Kidney Drug Civorebrutinib to Travere in Deal Worth Up to US$1.14 Billion
PremiumCompany AnnouncementsEverest Medicines Out-Licenses Kidney Drug Civorebrutinib to Travere in Deal Worth Up to US$1.14 Billion
10d ago
1952
Everest Medicines Sets EGM Timetable and Delays Acquisition Circular
Premium
Company Announcements
Everest Medicines Sets EGM Timetable and Delays Acquisition Circular
13d ago
1952
Everest Medicines’ Major Shareholder Lifts Stake in Confidence Boost
Premium
Company Announcements
Everest Medicines’ Major Shareholder Lifts Stake in Confidence Boost
21d ago
1952
Everest Medicines Director and Major Shareholder Raises Stake in Company
PremiumCompany Announcements
Everest Medicines Director and Major Shareholder Raises Stake in Company
28d ago
1952
Everest Medicines Details PSVT Asset Purchase and Readies for China Launch
PremiumCompany Announcements
Everest Medicines Details PSVT Asset Purchase and Readies for China Launch
2M ago
1952
Everest Medicines to Buy Asia-Pacific Chronic Disease Portfolio in US$250 Million Deal
PremiumCompany Announcements
Everest Medicines to Buy Asia-Pacific Chronic Disease Portfolio in US$250 Million Deal
2M ago
1952
Everest Medicines Honorary Chairman Boosts Stake in Company
PremiumCompany Announcements
Everest Medicines Honorary Chairman Boosts Stake in Company
2M ago
1952
Everest Medicines Publishes Audited 2025 Annual Results and Report
PremiumCompany AnnouncementsEverest Medicines Publishes Audited 2025 Annual Results and Report
3M ago
1952
Everest Medicines to Acquire Cardiovascular Drug Assets in Up to US$50 Million Deal
Premium
Company Announcements
Everest Medicines to Acquire Cardiovascular Drug Assets in Up to US$50 Million Deal
3M ago
1952
Everest Medicines Pays RMB200 Million Deposit for Potential Asia-Pacific Chronic Disease Portfolio Acquisition
Premium
Company Announcements
Everest Medicines Pays RMB200 Million Deposit for Potential Asia-Pacific Chronic Disease Portfolio Acquisition
3M ago
1952
Everest Medicines Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Everest Medicines Sets March 2026 Board Meeting to Approve 2025 Annual Results
3M ago
1952
Everest Medicines Shareholders Approve Commercial Pact and New 2026 Equity Incentive Scheme
PremiumCompany Announcements
Everest Medicines Shareholders Approve Commercial Pact and New 2026 Equity Incentive Scheme
4M ago
1952
Everest Medicines Wins China Approval for Ulcerative Colitis Drug VELSIPITY and Outlines Ambitious 2030 Growth Plan
PremiumCompany Announcements
Everest Medicines Wins China Approval for Ulcerative Colitis Drug VELSIPITY and Outlines Ambitious 2030 Growth Plan
4M ago
1952
Everest Medicines Secures Exclusive Asian Rights to First-in-Class SHPT Drug MT1013
PremiumCompany Announcements
Everest Medicines Secures Exclusive Asian Rights to First-in-Class SHPT Drug MT1013
4M ago
1952
Everest Medicines Calls Virtual EGM to Approve Commercial Deal and New Share Incentive Plan
PremiumCompany AnnouncementsEverest Medicines Calls Virtual EGM to Approve Commercial Deal and New Share Incentive Plan
4M ago
1952
Everest Medicines Sets February 2026 Date and Book Closure for Extraordinary General Meeting
Premium
Company Announcements
Everest Medicines Sets February 2026 Date and Book Closure for Extraordinary General Meeting
4M ago
1952
Everest Medicines Signs Connected Lease for Expanded Shanghai R&D and Production Site
Premium
Company Announcements
Everest Medicines Signs Connected Lease for Expanded Shanghai R&D and Production Site
5M ago
1952

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >